What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
Answer from: Radiation Oncologist at Academic Institution
There is no definitive evidence at this time that one of these imaging agents is clearly superior to the other because there are no comparative data in the same patient group.For Posluma, the potential benefit over Pylarify would be lower bladder excretion allowing for better visualization of the pe...
Comments
Radiation Oncologist at CarolinaEast Radiation Oncology Thank you @Michael J. Zelefsky. Is your institutio...
Radiation Oncologist at Desert Regional Comprehensive Cancer Center Our Nuclear medicine department preferred Illuccix...
Thank you @Michael J. Zelefsky. Is your institutio...
Our Nuclear medicine department preferred Illuccix...